BCBS Mississippi Medical Policy Updates – August 2018

Click here to view the Blue Cross Blue Shield Mississippi Medical Policy Updates »

August 2018 BCBS Mississippi Medical Policy Updates:

• Ablation Procedures for Peripheral Neuromas
• Accelerated Breast Irradiation and Brachytherapy Boost After Breast-Conserving Surgery for Early-Stage Breast Cancer
• Acute and Maintenance Tocolysis
• Alcohol Injections for Treatment of Peripheral Neuromas
• Anti-Rheumatic Biologicals – Effective 04/01/2018
• Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast Cancer
• Biofeedback as a Treatment of Urinary Incontinence in Adults
• Bone Mineral Density Studies
• Brachytherapy for Clinically Localized Prostate Cancer Using Permanently Implanted Seeds
• BRAF Gene Variant Testing To Select Melanoma or Glioma Patients for Targeted Therapy
• Bronchial Thermoplasty
• Bronchial Thermoplasty
• Bronchial Valves
• Cardiac Hemodynamic Monitoring for the Management of Heart Failure in the Outpatient Setting
• Cellular Immunotherapy for Prostate Cancer
• Charged-Particle (Proton or Helium Ion) Radiotherapy for Neoplastic Conditions
• Cranial Electrotherapy Stimulation (CES) and Auricular Electrostimulation
• Cryosurgical Ablation (Cryosurgery) of Primary or Metastatic Liver Tumors
• Cytochrome P450 Genotype-Guided Treatment Strategy
• Electromagnetic Navigation Bronchoscopy
• Electronic Brachytherapy for Nonmelanoma Skin Cancer
• Endobronchial Brachytherapy
• Endobronchial Valves
• Endometrial Ablation
• Genetic Testing
• Genetic Testing for Diagnosis and Management of Mental Health Conditions
• Genetic Testing for Li-Fraumeni Syndrome
• Genotype-Guided Tamoxifen Treatment
• High-Dose Rate Temporary Prostate Brachytherapy
• Home Cardiorespiratory Monitoring
• Implantable Infusion Pump
• Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence
• Intensity Modulated Radiation Therapy (IMRT) Abdomen and Pelvis
• Intensity-Modulated Radiatiotherapy (IMRT) of the Prostate
• Intensity-Modulated Radiotherapy of the Breast and Lung
• Intensity-Modulated Radiotherapy: Cancer of the Head and Neck or Thyroid
• Intensity-Modulated Radiotherapy: Central Nervous System Tumors
• Intracavitary Balloon Catheter Brain Brachytherapy for Malignant Gliomas or Metastasis to the Brain
• Intradialytic Parenteral Nutrition
• Intraoperative Radiotherapy
• Invasive Prenatal (Fetal) Diagnostic Testing
• JAK2, MPL, and CALR Testing for Myeloproliferative Neoplasms
• KRAS, NRAS, and BRAF Variant Analysis in Metastatic Colorectal Cancer
• Magnetic Resonance Imaging-Targeted Biopsy of the Prostate
• Moderate Penetrance Variants Associated With Breast Cancer in Individuals at High Breast Cancer Risk
• Molecular Markers in Fine Needle Aspirates of the Thyroid
• Occlusion of Uterine Arteries Using Transcatheter Embolization
• Oncologic Applications of Photodynamic Therapy, Including Barrett’s Esophagus
• Opioid and Opioid Combination Medications
• Orthognathic Surgery (Overbite/Underbite)
• Ovarian and Internal Iliac Vein Embolization as a Treatment of Pelvic Congestion Syndrome
• Pelvic Floor Stimulation as a Treatment of Urinary and Fecal Incontinence
• Percutaneous Electrical Nerve Stimulation (PENS) and Percutaneous Neuromodulation Therapy (PNT)
• Percutaneous Tibial Nerve Stimulation
• Periureteral Bulking Agents as a Treatment of Vesicoureteral Reflux
• Progesterone Therapy as a Technique to Reduce Preterm Delivery in High Risk Pregnancies
• Proteogenomic Testing for Patients With Cancer
• Radioembolization for Primary and Metastatic Tumors of the Liver
• Radiofrequency Ablation of Primary or Metastatic Liver Tumors
• Risk-Reducing Mastectomy
• Saturation Biopsy for Diagnosis, Staging, and Management of Prostate Cancer
• Serum Biomarker Panel Testing for Systemic Lupus Erythematosus and Other Connective Tissue Diseases
• Sleep Disorders – Effective 01/01/2018
• Sleep Disorders – Effective 01/01/2018
• Telehealth: Real-Time Interactive Telemedicine Services
• Telehealth: Store-and-Forward Telemedicine Services
• Transcatheter Arterial Chemoembolization to Treat Primary or Metastatic Liver Malignancies

Click here to view the Blue Cross Blue Shield Mississippi Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.